| Title : M1 muscarinic acetylcholine receptor in Alzheimer's disease - Jiang_2014_Neurosci.Bull_30_295 |
| Author(s) : Jiang S , Li Y , Zhang C , Zhao Y , Bu G , Xu H , Zhang YW |
| Ref : Neurosci Bull , 30 :295 , 2014 |
|
Abstract :
The degeneration of cholinergic neurons and cholinergic hypofunction are pathologies associated with Alzheimer's disease (AD). Muscarinic acetylcholine receptors (mAChRs) mediate acetylcholine-induced neurotransmission and five mAChR subtypes (M1-M5) have been identified. Among them, M1 mAChR is widely expressed in the central nervous system and has been implicated in many physiological and pathological brain functions. In addition, M1 mAChR is postulated to be an important therapeutic target for AD and several other neurodegenerative diseases. In this article, we review recent progress in understanding the functional involvement of M1 mAChR in AD pathology and in developing M1 mAChR agonists for AD treatment. |
| PubMedSearch : Jiang_2014_Neurosci.Bull_30_295 |
| PubMedID: 24590577 |
Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW (2014)
M1 muscarinic acetylcholine receptor in Alzheimer's disease
Neurosci Bull
30 :295
Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW (2014)
Neurosci Bull
30 :295